Full Text View
Tabular View
No Study Results Posted
Related Studies
EU PV for Retapamulin-Prescribing
This study is ongoing, but not recruiting participants.
Study NCT01153828   Information provided by GlaxoSmithKline

First Received on May 13, 2010.   Last Updated on April 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Impetigo
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Skin Diseases
Skin Diseases, Bacterial
Skin Diseases, Infectious
Staphylococcal Infections
Staphylococcal Skin Infections
Streptococcal Infections
Interventions listed in this trial
Retapamulin
Additional drug interventions recognized in this trial
Fusidic Acid
Mupirocin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services